(Q61455444)
Statements
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis (English)
Takashi Kumada
Toshifumi Tada
Masashi Hirooka
Toru Ishikawa
Koichi Takaguchi
Kazuto Tajiri
Noritomo Shimada
Hironori Ochi
Akemi Tsutsui
Norio Itokawa
Kojiro Michitaka
Kazuya Kariyama
Michitaka Imai
Masanori Atsukawa
Kazuhiro Nouso
Yoichi Hiasa
Kouji Joko
Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Ei Itobayashi
Kunihiko Tsuji
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference